168 related articles for article (PubMed ID: 29739097)
1. Could Endocan, a Marker of Inflammation and Endothelial Dysfunction, be a New Diagnostic Marker for Fibromyalgia?
Mertoglu C; Gunay M; Yerligok O
Clin Lab; 2018 Mar; 64(3):405-410. PubMed ID: 29739097
[TBL] [Abstract][Full Text] [Related]
2. Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis.
Aciksari G; Kavas M; Atici A; Kul S; Erman H; Yilmaz Y; Demircioglu K; Yalcinkaya E; Kanbay A; Caliskan M
Angiology; 2018 Nov; 69(10):878-883. PubMed ID: 29747515
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.
Ozalper V; Kara M; Tanoglu A; Cetındaglı I; Ozturker C; Hancerlı Y; Hıra S; Kara K; Beyazıt Y; Yazgan Y
Clin Rheumatol; 2017 Sep; 36(9):2071-2077. PubMed ID: 28074304
[TBL] [Abstract][Full Text] [Related]
4. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
[TBL] [Abstract][Full Text] [Related]
5. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
6. Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients.
Elkamshoushi AAM; Hassan EM; El Abd AM; Hassan SZ; Maher AA
Andrologia; 2018 Dec; 50(10):e13113. PubMed ID: 30039584
[TBL] [Abstract][Full Text] [Related]
7. Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.
Balamir I; Ates I; Topcuoglu C; Turhan T
Angiology; 2018 Aug; 69(7):609-616. PubMed ID: 29172652
[TBL] [Abstract][Full Text] [Related]
8. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
[TBL] [Abstract][Full Text] [Related]
9. Endocan: A biomarker for endothelial dysfunction and inflammation, linking maternal obesity and pediatric obesity in a cohort of preterm neonates.
Holthaus E; O'Neill M; Jeske W; DeChristopher P; Goodman J; Glynn L; Levin S; Muraskas J
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():132-137. PubMed ID: 38626514
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo.
Cox LA; van Eijk LT; Ramakers BP; Dorresteijn MJ; Gerretsen J; Kox M; Pickkers P
Shock; 2015 Apr; 43(4):322-6. PubMed ID: 25565643
[TBL] [Abstract][Full Text] [Related]
11. Serum endocan levels in patients with cardiac syndrome X.
Efe SC; Demirci K; Ozturk S; Gurbuz AS; Poci N; Kilicgedik A; Guler A; Yilmaz MF; İzgi IA; Kirma C
Herz; 2018 Jun; 43(4):359-363. PubMed ID: 28589439
[TBL] [Abstract][Full Text] [Related]
12. Higher Serum Endocan Level Is Associated with Alzheimer Disease.
Varan HD; Guner G; Kizilarslanoglu MC; Sumer F; Dogrul RT; Sagir A; Ozsurekci C; Caliskan H; Balci C; Aycicek GS; Akbiyik F; Halil M; Cankurtaran M; Yavuz BB
Dement Geriatr Cogn Disord; 2017; 44(5-6):303-310. PubMed ID: 29393258
[TBL] [Abstract][Full Text] [Related]
13. Endocan as a marker of disease severity in pulmonary thromboembolism.
Kuluöztürk M; İn E; İlhan N
Clin Respir J; 2019 Dec; 13(12):773-780. PubMed ID: 31556240
[TBL] [Abstract][Full Text] [Related]
14. Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim.
Gungor A; Palabiyik SS; Bayraktutan Z; Dursun H; Gokkaya N; Bilen A; Bilen H
Endocr Res; 2016 Nov; 41(4):275-280. PubMed ID: 26906498
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in patients with acromegaly and It's association with Endocan.
Kul S; Caklili OT; Tutuncu Y; Ozcan FB; Aksu F; Baycan OF; Atici A; Bilgili UZ; Takir M; Caliskan M
Growth Horm IGF Res; 2021 Feb; 56():101362. PubMed ID: 33221710
[TBL] [Abstract][Full Text] [Related]
16. Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.
Bălănescu P; Lădaru A; Bălănescu E; Voiosu T; Băicuş C; Dan GA
J Clin Lab Anal; 2016 Sep; 30(5):368-73. PubMed ID: 26331941
[TBL] [Abstract][Full Text] [Related]
17. Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan.
Celık T; Balta S; Karaman M; Ahmet Ay S; Demırkol S; Ozturk C; Dınc M; Unal HU; Yılmaz MI; Kılıc S; Kurt G; Tas A; Iyısoy A; Quartı-Trevano F; Fıcı F; Grassı G
Blood Press; 2015 Feb; 24(1):55-60. PubMed ID: 25390761
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of endocan correlate with the presence and severity of pre-eclampsia.
Cakmak M; Yilmaz H; Bağlar E; Darcin T; Inan O; Aktas A; Celik HT; Ozdemir O; Atalay CR; Akcay A
Clin Exp Hypertens; 2016; 38(2):137-42. PubMed ID: 26418319
[TBL] [Abstract][Full Text] [Related]
19. Serum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis.
Wu TJ; Wang CH; Lai YH; Kuo CH; Lin YL; Hsu BG
Medicina (Kaunas); 2024 Jun; 60(6):. PubMed ID: 38929601
[No Abstract] [Full Text] [Related]
20. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
Lv Y; Zhang Y; Shi W; Liu J; Li Y; Zhou Z; He Q; Wei S; Liu J; Quan J
Am J Med Sci; 2017 May; 353(5):433-438. PubMed ID: 28502328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
